{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:00:50Z","timestamp":1776394850614,"version":"3.51.2"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00210-025-04965-4","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:35:01Z","timestamp":1767850501000},"page":"8579-8596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Andrographolide augments methotrexate\u2019s therapeutic potential in psoriasis: comprehensive in vitro and in vivo evaluation"],"prefix":"10.1007","volume":"399","author":[{"given":"Chintan R.","family":"Khunt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepti K.","family":"Jani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"4965_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00210-025-04317-2","volume":"399","author":"AH Abbas","year":"2025","unstructured":"Abbas AH, Abbood MS, Ridha-Salman H, Fakhri SA, Abbas ZH, Al-Athari AJH (2025) Suppressive effect of topical moxifloxacin on imiquimod-induced model of psoriasis in mice. Naunyn Schmiedebergs Arch Pharmacol 399:1\u201320. https:\/\/doi.org\/10.1007\/s00210-025-04317-2","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4965_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jfb14010019","volume":"14","author":"MZ Ahmad","year":"2022","unstructured":"Ahmad MZ, Mohammed AA, Algahtani MS, Mishra A, Ahmad J (2022) Nanoscale topical pharmacotherapy in management of psoriasis: contemporary research and scope. J Funct Biomater 14:19. https:\/\/doi.org\/10.3390\/jfb14010019","journal-title":"J Funct Biomater"},{"key":"4965_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10735-025-10416-4","volume":"56","author":"BF Ali","year":"2025","unstructured":"Ali BF, Abu-Raghif AR, Ridha-Salman H, Al-Athari AJH (2025) Vildagliptin topical ointment: an effective treatment for imiquimod-induced psoriasis in mice. J Mol Histol 56:143. https:\/\/doi.org\/10.1007\/s10735-025-10416-4","journal-title":"J Mol Histol"},{"key":"4965_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6756138","volume":"2016","author":"P Alvarez","year":"2016","unstructured":"Alvarez P, Jensen LE (2016) Imiquimod treatment causes systemic disease in mice resembling generalized pustular psoriasis in an IL-1 and IL-36 dependent manner. Mediators Inflamm 2016:6756138. https:\/\/doi.org\/10.1155\/2016\/6756138","journal-title":"Mediators Inflamm"},{"key":"4965_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/toxres\/tfaf007","author":"RK Attarbashee","year":"2025","unstructured":"Attarbashee RK, Hamodat HF, Mammdoh JK, Ridha-Salman H (2025) The possible effect of Bosentan on the methotrexate-induced salivary gland changes in male rats: histological and immunohistochemical study. Toxicol Res. https:\/\/doi.org\/10.1093\/toxres\/tfaf007","journal-title":"Toxicol Res"},{"key":"4965_CR6","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3109\/10837450.2015.1026605","volume":"21","author":"V Avasatthi","year":"2016","unstructured":"Avasatthi V, Pawar H, Dora CP, Bansod P, Gill MS, Suresh S (2016) A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation. Pharm Dev Technol 21:554\u2013562. https:\/\/doi.org\/10.3109\/10837450.2015.1026605","journal-title":"Pharm Dev Technol"},{"key":"4965_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118623","volume":"569","author":"M Bahramizadeh","year":"2019","unstructured":"Bahramizadeh M, Bahramizadeh M, Kiafar B, Jafarian AH, Nikpoor AR, Hatamipour M, Esmaily H, Rezaeemehr Z, Golmohammadzadeh S, Moosavian SA, Jafari MR (2019) Development, characterization and evaluation of topical methotrexate-entrapped deformable liposome on imiquimod-induced psoriasis in a mouse model. Int J Pharm 569:118623. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118623","journal-title":"Int J Pharm"},{"key":"4965_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1365-2133.1992.tb07805.x","volume":"126","author":"BS Baker","year":"1992","unstructured":"Baker BS, Brent L, Valdimarsson H, Powles AV, Al-Imara L, Walker M, Fry L (1992) Is epidermal cell proliferation in psoriatic skin grafts on nude mice driven by T-cell derived cytokines? Br J Dermatol 126:105\u2013110. https:\/\/doi.org\/10.1111\/j.1365-2133.1992.tb07805.x","journal-title":"Br J Dermatol"},{"key":"4965_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/PTT.S294173","volume":"11","author":"H Ben Abdallah","year":"2021","unstructured":"Ben Abdallah H, Johansen C, Iversen L (2021) Key signaling pathways in psoriasis: recent insights from antipsoriatic therapeutics. Psoriasis (Auckl) 11:83\u201397. https:\/\/doi.org\/10.2147\/PTT.S294173","journal-title":"Psoriasis (Auckl)"},{"key":"4965_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.adengl.2016.01.025","volume":"107","author":"JM Carrascosa","year":"2016","unstructured":"Carrascosa JM, De La Cueva P, Ara M, Puig L, Bordas X, Carretero G, Ferr\u00e1ndiz L, S\u00e1nchez-Carazo JL, Daud\u00e9n E, L\u00f3pez-Estebaranz JL, Vidal D (2016) Methotrexate in moderate to severe psoriasis: review of the literature and expert recommendations. Actas Dermosifiliogr 107:194\u2013206. https:\/\/doi.org\/10.1016\/j.adengl.2016.01.025","journal-title":"Actas Dermosifiliogr"},{"key":"4965_CR11","doi-asserted-by":"publisher","first-page":"854","DOI":"10.2340\/00015555-2359","volume":"96","author":"JC Chamcheu","year":"2016","unstructured":"Chamcheu JC, Chaves-Rodriquez MI, Adhami VM, Siddiqui IA, Wood GS, Longley B, Mukhtar H (2016) Upregulation of PI3K\/AKT\/mTOR, FABP5 and PPAR\u03b2\/\u03b4 in human psoriasis and imiquimod-induced murine psoriasiform dermatitis model. Acta Derm Venereol 96:854\u2013856. https:\/\/doi.org\/10.2340\/00015555-2359","journal-title":"Acta Derm Venereol"},{"key":"4965_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156398","volume":"172","author":"R Choudhary","year":"2023","unstructured":"Choudhary R, Saroch D, Kumar D, Anjum S, Andrabi NI, Akram T, Shah BA, Shukla SK, Bhagat A, Kour G, Ahmed Z (2023) Anti-inflammatory and anti-arthritic potential of methotrexate in combination with BA-25, an amino analogue of \u03b2-boswellic acid in the treatment of rheumatoid arthritis. Cytokine 172:156398. https:\/\/doi.org\/10.1016\/j.cyto.2023.156398","journal-title":"Cytokine"},{"key":"4965_CR13","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1080\/10408398.2018.1501657","volume":"59","author":"Y Dai","year":"2019","unstructured":"Dai Y, Chen SR, Chai L, Zhao J, Wang Y, Wang Y (2019) Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide. Crit Rev Food Sci Nutr 59:S17-29. https:\/\/doi.org\/10.1080\/10408398.2018.1501657","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4965_CR14","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.3390\/ijms22179294","volume":"22","author":"K Dopytalska","year":"2021","unstructured":"Dopytalska K, Ciechanowicz P, Wiszniewski K, Szyma\u0144ska E, Walecka I (2021) The role of epigenetic factors in psoriasis. Int J Mol Sci 22:9294. https:\/\/doi.org\/10.3390\/ijms22179294","journal-title":"Int J Mol Sci"},{"key":"4965_CR15","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.12991\/jrespharm.1734970","volume":"29","author":"BA Farooq","year":"2025","unstructured":"Farooq BA, Abu-raghif AR, Ridha-Salman H (2025a) Protective effect of cinnarizine on imiquimod-induced mouse model of psoriasis. J Res Pharm 29:1783\u20131791. https:\/\/doi.org\/10.12991\/jrespharm.1734970","journal-title":"J Res Pharm"},{"key":"4965_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117801","volume":"183","author":"M Farooq","year":"2025","unstructured":"Farooq M, Ahmad B, Han JH, Patra MC, Khan AW, Choi H, Seo H, Choi H, Kim MS, Kim W, Choi S (2025b) Rational design and therapeutic potential of MyD88 inhibitory peptide in psoriasis. Biomed Pharmacother 183:117801. https:\/\/doi.org\/10.1016\/j.biopha.2024.117801","journal-title":"Biomed Pharmacother"},{"key":"4965_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113388","volume":"143","author":"F Ferrara","year":"2024","unstructured":"Ferrara F, Verduci C, Laconi E, Mangione A, Dondi C, Del Vecchio M, Carlevatti V, Zovi A, Capuozzo M, Langella R (2024) Current therapeutic overview and future perspectives regarding the treatment of psoriasis. Int Immunopharmacol 143:113388. https:\/\/doi.org\/10.1016\/j.intimp.2024.113388","journal-title":"Int Immunopharmacol"},{"key":"4965_CR18","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1002\/EJI.201343801","volume":"43","author":"B Flutter","year":"2013","unstructured":"Flutter B, Nestle FO (2013) Tlrs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis. Eur J Immunol 43:3138\u20133146. https:\/\/doi.org\/10.1002\/EJI.201343801","journal-title":"Eur J Immunol"},{"key":"4965_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo J, Zhang H, Lin W, Lu L, Su J, Chen X (2023) Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther 8:437. https:\/\/doi.org\/10.1038\/s41392-023-01655-6","journal-title":"Signal Transduct Target Ther"},{"key":"4965_CR20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s12276-021-00620-z","volume":"53","author":"L Hao","year":"2021","unstructured":"Hao L, Mao Y, Park J, Kwon BM, Bae EJ, Park BH (2021) 2\u2032-hydroxycinnamaldehyde ameliorates imiquimod-induced psoriasiform inflammation by targeting PKM2-STAT3 signaling in mice. Exp Mol Med 53:875\u2013884. https:\/\/doi.org\/10.1038\/s12276-021-00620-z","journal-title":"Exp Mol Med"},{"key":"4965_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jid.2016.10.024","volume":"137","author":"JE Hawkes","year":"2017","unstructured":"Hawkes JE, Gudjonsson JE, Ward NL (2017) The snowballing literature on imiquimod-induced skin inflammation in mice: a critical appraisal. J Invest Dermatol 137:546\u2013549. https:\/\/doi.org\/10.1016\/j.jid.2016.10.024","journal-title":"J Invest Dermatol"},{"key":"4965_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/life11040305","volume":"11","author":"H Kaiser","year":"2021","unstructured":"Kaiser H, Kvist-Hansen A, Krakauer M, G\u00f8rtz PM, Henningsen KM, Wang X, Becker C, Zachariae C, Skov L, Hansen PR (2021) Association between vascular inflammation and inflammation in adipose tissue, spleen, and bone marrow in patients with psoriasis. Life 11:305. https:\/\/doi.org\/10.3390\/life11040305","journal-title":"Life"},{"issue":"8","key":"4965_CR23","doi-asserted-by":"publisher","first-page":"6231","DOI":"10.1007\/s00210-024-03017-7","volume":"397","author":"AWM Khafaji","year":"2024","unstructured":"Khafaji AWM, Al-Zubaidy AAK, Farhood IG, Salman HR (2024) Ameliorative effects of topical ramelteon on imiquimod-induced psoriasiform inflammation in mice. Naunyn Schmiedebergs Arch Pharmacol 397(8):6231\u20136248. https:\/\/doi.org\/10.1007\/s00210-024-03017-7","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4965_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.113646","volume":"170","author":"N Kim","year":"2019","unstructured":"Kim N, Lertnimitphun P, Jiang Y, Tan H, Zhou H, Lu Y, Xu H (2019) Andrographolide inhibits inflammatory responses in LPS-stimulated macrophages and murine acute colitis through activating AMPK. Biochem Pharmacol 170:113646. https:\/\/doi.org\/10.1016\/j.bcp.2019.113646","journal-title":"Biochem Pharmacol"},{"key":"4965_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/J.HELIYON.2023.E20151","volume":"9","author":"S Lallo","year":"2023","unstructured":"Lallo S, Hardianti B, Djabir YY, Ismail I, Indrisari M, Aswad M, Hertati A, Habibie H, Hayakawa Y (2023) Piper retrofractum ameliorates imiquimod-induced skin inflammation via modulation of TLR4 axis and suppression of NF-\u03baB activity. Heliyon 9:e20151. https:\/\/doi.org\/10.1016\/J.HELIYON.2023.E20151","journal-title":"Heliyon"},{"key":"4965_CR26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jep.2014.10.056","volume":"158","author":"TY Lee","year":"2014","unstructured":"Lee TY, Chang HH, Wen CK, Huang TH, Chang YS (2014) Modulation of thioacetamide-induced hepatic inflammations, angiogenesis and fibrosis by andrographolide in mice. J Ethnopharmacol 158:423\u2013430. https:\/\/doi.org\/10.1016\/j.jep.2014.10.056","journal-title":"J Ethnopharmacol"},{"key":"4965_CR27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.biopha.2018.07.001","volume":"106","author":"F Li","year":"2018","unstructured":"Li F, Li H, Luo S, Ran Y, Xie X, Wang Y, Zheng M, Wang M, Zhao Z, Li X (2018) Evaluation of the effect of andrographolide and methotrexate combined therapy in complete Freund\u02bcs adjuvant induced arthritis with reduced hepatotoxicity. Biomed Pharmacother 106:637\u2013645. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.001","journal-title":"Biomed Pharmacother"},{"key":"4965_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8248142","volume":"2017","author":"Y Li","year":"2017","unstructured":"Li Y, He S, Tang J, Ding N, Chu X, Cheng L, Ding X, Liang T, Feng S, Rahman SU, Wang X (2017) Andrographolide inhibits inflammatory cytokines secretion in LPS-stimulated RAW264.7 cells through suppression of NF-\u03baB\/MAPK signaling pathway. Evid Based Complement Alternat Med 2017:8248142. https:\/\/doi.org\/10.1155\/2017\/8248142","journal-title":"Evid Based Complement Alternat Med"},{"key":"4965_CR29","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.biopha.2018.10.062","volume":"109","author":"Y Li","year":"2019","unstructured":"Li Y, Zhang G, Chen M, Tong M, Zhao M, Tang F, Xiao R, Wen H (2019) Rutaecarpine inhibited imiquimod-induced psoriasis-like dermatitis via inhibiting the NF-\u03baB and TLR7 pathways in mice. Biomed Pharmacother 109:1876\u20131883. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.062","journal-title":"Biomed Pharmacother"},{"key":"4965_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","volume":"181","author":"MS Maddur","year":"2012","unstructured":"Maddur MS, Miossec P, Kaveri SV, Bayry J (2012) Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 181:8\u201318. https:\/\/doi.org\/10.1016\/j.ajpath.2012.03.044","journal-title":"Am J Pathol"},{"key":"4965_CR31","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/J.JID.2022.12.013","volume":"143","author":"Q Meng","year":"2023","unstructured":"Meng Q, Bai M, Guo M, Li Z, Liu W, Fan X, Sun R, Yang X, Yuan D, Shi Y, Deng H (2023) Inhibition of serum-and glucocorticoid-regulated protein kinase-1 aggravates Imiquimod-induced psoriatic dermatitis and enhances proinflammatory cytokine expression through the NF-kB pathway. J Invest Dermatol 143:954\u2013964. https:\/\/doi.org\/10.1016\/J.JID.2022.12.013","journal-title":"J Invest Dermatol"},{"key":"4965_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.126099","volume":"684","author":"E Momtaz","year":"2025","unstructured":"Momtaz E, Mehrgardi MA (2025) Electro-responsive paper patch for enhanced transdermal methotrexate delivery in psoriasis treatment. Int J Pharm 684:126099. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.126099","journal-title":"Int J Pharm"},{"key":"4965_CR33","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.3390\/ijms25105306","volume":"25","author":"K Nazimek","year":"2024","unstructured":"Nazimek K, Bryniarski K (2024) Macrophage functions in psoriasis: lessons from mouse models. Int J Mol Sci 25:5306. https:\/\/doi.org\/10.3390\/ijms25105306","journal-title":"Int J Mol Sci"},{"key":"4965_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/ejh.13547","volume":"106","author":"M Pizzi","year":"2021","unstructured":"Pizzi M, Friziero A, Vianello F, Binotto G, Da Dalt G, Zoletto S, Carraro E, Fassan M, Sbaraglia M, Sperti C, Baldan N (2021) Histology of the spleen in immune thrombocytopenia: clinical-pathological characterization and prognostic implications. Eur J Haematol 106:281\u2013289. https:\/\/doi.org\/10.1111\/ejh.13547","journal-title":"Eur J Haematol"},{"key":"4965_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K (2019) Psoriasis pathogenesis and treatment. Int J Mol Sci 20:1475. https:\/\/doi.org\/10.3390\/ijms20061475","journal-title":"Int J Mol Sci"},{"key":"4965_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.12788\/cutis.0579","volume":"110","author":"KA Reynolds","year":"2022","unstructured":"Reynolds KA, Pithadia DJ, Lee EB, Clarey D, Liao W, Wu JJ (2022) Generalized pustular psoriasis: a review of the pathophysiology, clinical manifestations, diagnosis, and treatment. Cutis 110:19\u201325. https:\/\/doi.org\/10.12788\/cutis.0579","journal-title":"Cutis"},{"key":"4965_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00210-024-03406-y","volume":"398","author":"H Ridha-Salman","year":"2024","unstructured":"Ridha-Salman H, Al-Zubaidy AA, Abbas AH, Hassan DM, Malik SA (2024) The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation. Naunyn Schmiedebergs Arch Pharmacol 398:1\u201321. https:\/\/doi.org\/10.1007\/s00210-024-03406-y","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4965_CR38","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bcp.2016.06.001","volume":"115","author":"F Shao","year":"2016","unstructured":"Shao F, Tan T, Tan Y, Sun Y, Wu X, Xu Q (2016) Andrographolide alleviates imiquimod-induced psoriasis in mice via inducing autophagic proteolysis of MyD88. Biochem Pharmacol 115:94\u2013103. https:\/\/doi.org\/10.1016\/j.bcp.2016.06.001","journal-title":"Biochem Pharmacol"},{"key":"4965_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1424219","volume":"15","author":"L Shu","year":"2024","unstructured":"Shu L, Fu H, Pi A, Feng Y, Dong H, Si C, Li S, Zhu F, Zheng P, Zhu Q (2024) Protective effect of andrographolide against ulcerative colitis by activating Nrf2\/HO-1 mediated antioxidant response. Front Pharmacol 15:1424219. https:\/\/doi.org\/10.3389\/fphar.2024.1424219","journal-title":"Front Pharmacol"},{"key":"4965_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","volume":"66","author":"I Sieminska","year":"2024","unstructured":"Sieminska I, Pieniawska M, Grzywa TM (2024) The immunology of psoriasis\u2014current concepts in pathogenesis. Clin Rev Allergy Immunol 66:164\u2013191. https:\/\/doi.org\/10.1007\/s12016-024-08991-7","journal-title":"Clin Rev Allergy Immunol"},{"key":"4965_CR41","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4103\/0378-6323.152175","volume":"81","author":"SK Singh","year":"2015","unstructured":"Singh SK, Rai T (2015) Relapse in psoriasis with two different tapering regimens of methotrexate: a randomized open-label controlled study. Indian J Dermatol Venereol Leprol 81:144\u2013147","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"4965_CR42","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/j.jid.2019.05.019","volume":"139","author":"A Srivastava","year":"2019","unstructured":"Srivastava A, Meisgen F, Pasquali L, Munkhammar S, Xia P, St\u00e5hle M, Land\u00e9n NX, Pivarcsi A, Sonkoly E (2019) Next-generation sequencing identifies the keratinocyte-specific miRNA signature of psoriasis. J Invest Dermatol 139:2547\u20132550. https:\/\/doi.org\/10.1016\/j.jid.2019.05.019","journal-title":"J Invest Dermatol"},{"key":"4965_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bcp.2017.03.024","volume":"139","author":"WSD Tan","year":"2017","unstructured":"Tan WSD, Liao W, Zhou S, Wong WSF (2017) Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action. Biochem Pharmacol 139:71\u201381. https:\/\/doi.org\/10.1016\/j.bcp.2017.03.024","journal-title":"Biochem Pharmacol"},{"key":"4965_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/MI\/2006\/16043","volume":"2006","author":"NS Tekin","year":"2006","unstructured":"Tekin NS, Ilter N, Sancak B, Ozden MG, Gurer MA (2006) Nitric oxide levels in patients with psoriasis treated with methotrexate. Mediators Inflamm 2006:016043. https:\/\/doi.org\/10.1155\/MI\/2006\/16043","journal-title":"Mediators Inflamm"},{"key":"4965_CR45","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L Van Der Fits","year":"2009","unstructured":"Van Der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J Immunol 182:5836\u20135845. https:\/\/doi.org\/10.4049\/jimmunol.0802999","journal-title":"J Immunol"},{"key":"4965_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-02846-z","volume":"316","author":"K Wang","year":"2024","unstructured":"Wang K, Zhao Y, Cao X (2024) Global burden and future trends in psoriasis epidemiology: insights from the global burden of disease study 2019 and predictions to 2030. Arch Dermatol Res 316:114. https:\/\/doi.org\/10.1007\/s00403-024-02846-z","journal-title":"Arch Dermatol Res"},{"key":"4965_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17315","volume":"9","author":"M Wang","year":"2023","unstructured":"Wang M, Yin X, Zeng Y, Hu C, Xue Y, Fang Q, Qiao X, Zhao X, Du C, Huang F, Lin Y (2023) Extracts from Seseli mairei Wolff attenuate imiquimod-induced psoriasis-like inflammation by inhibiting Th17 cells. Heliyon 9:e17315. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17315","journal-title":"Heliyon"},{"key":"4965_CR48","unstructured":"West-Ward Pharmaceuticals Corp USA. Highlights of Prescribing Information: Methotrexate Tablets. 2020. U.S. Food and Drug Administration. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/040054s015,s016,s017.pdf"},{"key":"4965_CR49","doi-asserted-by":"publisher","first-page":"6973","DOI":"10.4049\/jimmunol.173.11.6973","volume":"173","author":"CH Woo","year":"2004","unstructured":"Woo CH, Lim JH, Kim JH (2004) Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7 cells. J Immunol 173:6973\u20136980. https:\/\/doi.org\/10.4049\/jimmunol.173.11.6973","journal-title":"J Immunol"},{"key":"4965_CR50","doi-asserted-by":"publisher","DOI":"10.1177\/039463202412602","volume":"38","author":"L Xu","year":"2024","unstructured":"Xu L, Jiang Y, Xu F, Liu J, Jiang Y, Fang F, Luo L (2024) Deucravacitinib and shikonin combination therapy ameliorates imiquimod-induced psoriasis in mice. Int J Immunopathol Pharmacol 38:03946320241260262. https:\/\/doi.org\/10.1177\/039463202412602","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4965_CR51","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/bjd.16560","volume":"179","author":"K Yan","year":"2018","unstructured":"Yan K, Xu W, Huang Y, Zhang Z, Huang Q, Xin KZ, Ma Y, Han L (2018) Methotrexate restores the function of peripheral blood regulatory T cells in psoriasis vulgaris via the CD73\/AMPK\/mTOR pathway. Br J Dermatol 179:896\u2013905. https:\/\/doi.org\/10.1111\/bjd.16560","journal-title":"Br J Dermatol"},{"key":"4965_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24112157","volume":"24","author":"BY Yang","year":"2019","unstructured":"Yang BY, Cheng YG, Liu Y, Liu Y, Tan JY, Guan W, Guo S, Kuang HX (2019) Datura metel L. ameliorates imiquimod-induced psoriasis-like dermatitis and inhibits inflammatory cytokines production through TLR7\/8\u2013MyD88\u2013NF-\u03baB\u2013NLRP3 inflammasome pathway. Molecules 24:2157. https:\/\/doi.org\/10.3390\/molecules24112157","journal-title":"Molecules"},{"key":"4965_CR53","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1515\/biol-2020-0009","volume":"15","author":"J Zhang","year":"2020","unstructured":"Zhang J, Yang X, Qiu H, Chen W (2020) Weight loss may be unrelated to dietary intake in the imiquimod-induced plaque psoriasis mice model. Open Life Sci 15:79\u201382. https:\/\/doi.org\/10.1515\/biol-2020-0009","journal-title":"Open Life Sci"},{"key":"4965_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113074","volume":"150","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Hua Z, Luo X, Li Y, Yu L, Li M, Lu C, Zhao T, Liu Y (2022) Application and pharmacological mechanism of methotrexate in rheumatoid arthritis. Biomed Pharmacother 150:113074. https:\/\/doi.org\/10.1016\/j.biopha.2022.113074","journal-title":"Biomed Pharmacother"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04965-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04965-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04965-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T02:38:23Z","timestamp":1776393503000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04965-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4965"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04965-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was carried out with prior approval from the Institutional Animal Ethics Committee (IAEC) of the Department of Pharmaceutical Sciences, Saurashtra University, Rajkot, India (IAEC No. IAEC\/DPS\/SU\/2413), and care of animals complied with the Committee for Control and Supervision of Experiments on Animals (CCSEA) guidelines, Government of India.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}